SCHEMBL22964477

SCHEMBL22964477

CC(CO)(CO)c1ccc(Br)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.34
PDE2A O00408 2/20 0.33
APP P05067 1/20 0.33
CYP1A2 P05177 4/20 0.33
KDM1A O60341 3/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RCOR1 Q9UKL0 1/20 0.33
KCNH2 Q12809 2/20 0.33
ALOX15 P16050 2/20 0.33
ALOX12 P18054 2/20 0.33
KDM1B Q8NB78 1/20 0.33
KIF11 P52732 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29446073 1.00 ADRB2 (0.34) ADRB2PDE2AAPPCYP1A2KDM1A
SCHEMBL30636536 0.81 KDM1A (0.34) PDE2ACYP1A2KDM1ACYP2D6CYP2C9
SCHEMBL20972130 0.81 KDM1A (0.34) PDE2ACYP1A2KDM1ACYP2D6CYP2C9
SCHEMBL22021976 0.80 ESR1 (0.38) PDE2ACYP1A2KDM1ACYP2D6CYP2C9
SCHEMBL4153765 0.78 ALOX15 (0.46) PDE2AAPPKDM1ARCOR1KCNH2
SCHEMBL1104683 0.78 ALDH1A1 (0.41) CYP1A2KDM1ACYP2C19RCOR1KCNH2
SCHEMBL16046268 0.76 KDM1A (0.36) PDE2AAPPKDM1ARCOR1KCNH2
SCHEMBL31082039 0.75 PDE2A (0.41) PDE2AAPPKDM1ARCOR1KCNH2
SCHEMBL25341394 0.74 PDE2A (0.35) PDE2AAPPKDM1AKCNH2ALOX15
SCHEMBL27858715 0.73 KDM1A (0.39) PDE2AKDM1ARCOR1KCNH2KDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4007752-B1 KIF18A INHIBITORS AMGEN INC (US) 2025-09-24 EP disclosed
US-20220289724-A1 KIF18A INHIBITORS AMGEN INC. (US) 2022-09-15 US disclosed
EP-4007752-A1 KIF18A INHIBITORS Amgen Inc. (US) 2022-06-08 EP disclosed
CN-114302880-A KIF18A inhibitors 美国安进公司 2022-04-08 CN disclosed
WO-2021026098-A1 KIF18A INHIBITORS AMGEN INC. (US) 2021-02-11 WO disclosed
WO-2021026098-A1 KIF18A INHIBITORS AMGEN INC. (US) 2021-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289724-A1 KIF18A INHIBITORS KIF18A, KIF18B, KIF15 ADRB2 4461/4885PDE2A 3206/4885APP 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.